Catch up on the most-well viewed prostate cancer imaging content in July 2024.
Touching on a variety of topics, ranging from locoregional staging and mpMRI-targeted biopsies to an emerging PSMA agent for metastatic castration-resistant prostate cancer (mCRPC), here are the top five most well-viewed prostate cancer imaging content for July 2024.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.